TrialMedicine2017

Efficacy and safety of micafungin for the treatment of patients with proven or probable invasive aspergillosis: A non-comparative, multicenter, phase IV, open-label study.

Yu Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.